| | |
| Clinical data | |
|---|---|
| Other names | Methylguvacine; Arecaine; N-Methylguvacine |
| Drug class | GABA reuptake inhibitor |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C7H11NO2 |
| Molar mass | 141.170 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Arecaidine, also known as N-methylguvacine, is an alkaloid in areca nuts and a GABA reuptake inhibitor. [1] [2] [3] It is structurally similar to the GABA reuptake inhibitors guvacine and nipecotic acid. [1] Arecaidine has been found to produce sedative effects in mice and to protect against the lethality of the GABAA receptor antagonists bicuculline and pentylenetetrazol. [3] On the other hand, it did not produce anticonvulsant effects. [3] Lime is said to hydrolyse arecoline to arecaidine. [2]